Dr Rakić: "People should benefit from data sharing!"

The advancement of biomedicine, clinical practice, and pharmacy is intrinsically tied to the application of artificial intelligence in the fields of diagnostic process automation, therapeutic decision-making, and clinical research, drug discovery, clinical trials, and personalized medicine.

Do public authorities use legitimate grounds for sharing personal data, to what extent are the IT platforms used for data sharing compliant with the GDPR and applicable standards, how to apply anonymisation best practices for sharing data for research purposes, and how privacy risks are assessed under the GDPR-in the context of the use of artificial intelligence, the panelists discussed:

• Dr Branka Rakić, the Institute for Artificial Intelligence of Serbia;
• Ms Jelena Bojović, director of the Centre for the Fourth Industrial Revolution;
• Prof. dr. Vladimir Crnojević, Director of the BioSense Institute;
• Dr. Branka Zukić, Leader of the Pharmacogenomics group within the Laboratory for Molecular Biomedicine in the Institute for Molecular Genetics and Genetic Engineering, Belgrade University;
• Mr. Milan Gospić – Director of Microsoft Serbia;
• Ms Dragana Stojković, Chief of Department for Normative Affairs for Business and Finance Work and Public Affairs at Commissioner for Information of Public Importance and Protection of Personal Data
• Dr Stefan Brink, The Commissioner for Information of Freedom and Personal Data Protection in Baden Wuertemberg, Germany.

"It is interesting that people who work in science and research are always more open to sharing data and are much less afraid, because they believe the dangers are somewhere else than people who work in law and legislation. Our job, like other institutions, is to get data within those legal norms, frameworks that already exist in order to ensure safe data use. In our situation, it pertains to patients, since we don't want to endanger their privacy, but we want to develop something valuable with that data that will convince others that there is no need to be frightened, because they should profit if they share data", says Dr. Branka Rakić, senior associate at the Institute for Artificial Intelligence of Serbia.

The goal of the JPM International GDPR Conference is to present the best practices of European and domestic authorities for personal data protection, as well as the practices of experts, scientists, and technological leaders, in order to generate new ideas and advice on how to strike a balance between the use of artificial intelligence and the application of GDPR- and in the field of healthcare and pharmacy.